TuHURA Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
TuHURA Biosciences said President and CEO James A. Bianco, M.D. will present at the H.C. Wainwright 28th Annual Global Investment Conference in New York on Monday, September 14 at 4:00pm ET.
Key figures
- Mut NPM1 share of AML patients
- approximately 35%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.